For many individuals with end-stage renal illness who are on continuous dialysis, transplantation is one of the preferred therapeutic alternatives. Transplantation is also a potential choice in cases involving the heart, liver, and bone marrow. Furthermore, diagnostics have advanced dramatically over the last decade as companies have committed to developing better HLA typing technologies, antibody monitoring, devices, and software. This is rapidly being used for diagnostics during the transplantation of various organs.
Data Bridge Market Research analyzes that the Global Transplant Diagnostics Market is expected to reach a value of USD 10,139.38 million by 2029, at a CAGR of 6.8% during the forecast period of 2022-2029.
“Growing number of organ donors is bolstering the market growth”
According to figures released by the Association of Organ Procurement Organizations (AOPO) in January 2021, over 12,500 persons donated one or more organs in 2020, an increase of 6% from the previous year. The number of organs donated by deceased donors climbed by over 2% year on year to over 36,500 in 2020. It also stated that during the last seven years, organs from the dead had saved over 33,000 lives, outnumbering the prior year's totals. There were also significant increases in donations after circulatory death (DCD), which totaled over 3,000 donors in 2020. Higher organ donation necessitates higher transplant diagnostic testing, which fuels market expansion.
What restraints the growth of the Global Transplant Diagnostics Market?
“High costs associated will restrain the market growth"
Organ transplantation therapy makes use of cutting-edge technology. The production of these items necessitates extensive research and development on the part of the developing players. As a result, the cost of methods and products stays high, increasing the cost of testing accordingly. Also, organ transplants are expensive since they require a lot of resources, such as high-paid doctors, transportation, and pricey pharmaceuticals. Desensitizing medicines have also been utilized to complete a transplant from an incompatible donor. However, such operations are prohibitively expensive and may result in complications and poor long-term outcomes. As a result, the high cost of transplantation and treatment employing modern modalities and technological goods would be a major impediment to the worldwide transplant diagnostics market's growth.
Segmentation: Global Transplant Diagnostics Market
The global transplant diagnostics market is segmented into product type, technology, transplant type, application, end user and distribution channel.
- On the basis of product type, the global transplant diagnostics market is segmented into transplant diagnostic instrument, transplant diagnostic software and transplant diagnostic reagent.
- On the basis of technology, the global transplant diagnostics market is segmented into PCR-based molecular assays and sequencing-based molecular assays.
- On the basis of transplant type, the global transplant diagnostics market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation, bone marrow transplantation and other transplants.
- On the basis of application, the global transplant diagnostics market is segmented into diagnostic applications and research applications.
- On the basis of end user, the global transplant diagnostics market is segmented into research laboratories and academic institutes, hospitals and transplant centers, commercial service providers and others.
Regional Insights: North America dominates the Global Transplant Diagnostics Market
North America has the highest revenue share. Major causes include the widespread use of improved methods and diagnostic technologies, increased healthcare spending, and a scarcity of competent experts. Because of variables such as highly developed healthcare infrastructure and the availability of competent personnel, the United States has the biggest market share.
Given the presence of important market participants in the largest consumer market with a high GDP, Asia-Pacific will have the fastest growth rate. Furthermore, the widespread use of personalized medications, stem cell therapies, and soft tissue transplants is boosting regional market growth.
To know more about the study, visit, https://www.databridgemarketresearch.com/fr/reports/global-transplant-diagnostics-market
The Prominent Key Players Operating in the Global Transplant Diagnostics Market Include:
- Hologic, Inc.(U.S.)
- Biofortuna Limited (U.K.)
- Diagnóstica Longwood SL (Spain)
- Takara Bio Inc (China).
- Abbott (U.S.)
- B.D. (U.S.)
- Arquer Diagnostics Ltd (U.K.)
- altona Diagnostics GmbH (Germany)
- Transonic (India)
- Bio-Rad Laboratories, Inc. (U.S.)
- Zimmer Biomet (U.S.)
- Stryker Corporation (U.S.)
- QIAGEN
- F. Eurofins Scientific (Luxembourg)
- MDxHealth (Belgium)
- CareDx (U.S.)
- Immucor (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Menarini Silicon Biosystems (U.S.)
- Exosome Diagnostics Inc. (U.S.)
- Illumina, Inc. (U.S.)
- Genomic Health Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
Above are the key players covered in the report, to know about more and exhaustive list of global transplant diagnostics market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Transplant Diagnostics Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
